Hi there! How can I help you today?

I m 2yr mbbs student i have exams near me i m doing pgarmacology subject can u help me in this

Absolutely! I'm here to help you with Pharmacology for your MBBS exams. I have access to medical textbooks and can explain concepts clearly.

Here are some ways I can help:

📚 Topic Explanations

Drug mechanisms of action
Pharmacokinetics & pharmacodynamics
Drug classes and their clinical uses
Side effects, contraindications, drug interactions

🎯 Exam-Focused Help

Important drugs to remember
High-yield topics for 2nd year MBBS
Mnemonics and memory tricks
MCQ-style practice questions

Common 2nd Year Pharmacology Topics:

Autonomic Nervous System drugs (adrenergic, cholinergic)
CVS drugs (antihypertensives, antiarrhythmics, antianginals)
CNS drugs (sedatives, antiepileptics, antipsychotics)
Antibiotics & Antimicrobials
Autacoids, NSAIDs
Chemotherapy

Just tell me:

Which topic do you want to study?
Any specific drug or concept you're confused about?
Or if you want, I can give you high-yield exam questions on a topic!

What would you like to start with? 😊

I almost completed it only 1 chapter left you help me in that It is antimicrobial chapter

Great choice! Antimicrobials is one of the most important and high-yield chapters in 2nd year Pharmacology.

Let me know how you'd like to approach it:

Asking for Preferences

How would you like to study Antimicrobials? · Which area of Antimicrobials do you want to focus on?

Antifungal drugs

Great topic! Let me pull up the full antifungal content from medical textbooks for you.

Searching sources...

Reading File

Finding Sources

Now let me read the most relevant sections from Goldman-Cecil Medicine (comprehensive antifungal agents section):

Reading File

Now let me get the core pharmacology of antifungal drugs (mechanisms, classes):

Finding Sources

Excellent! I found Lippincott (perfect for MBBS). Let me read that section fully:

Reading File

Finding Sources

Reading File

I now have all the information I need. Let me fetch the key diagram image to include:

Loading Image

Here is your complete, exam-ready guide on Antifungal Drugs - straight from Lippincott Pharmacology and other standard textbooks!

🍄 ANTIFUNGAL DRUGS - Complete MBBS Guide

Overview: Targets of Antifungal Drugs

Fungi are eukaryotes, so antifungals must target structures unique to fungi to avoid harming the host. The three main targets are:

Target	Drug Class
Ergosterol (fungal cell membrane)	Polyenes (Amphotericin B), Azoles
Ergosterol synthesis	Azoles, Allylamines (Terbinafine)
Cell wall (β-1,3-glucan)	Echinocandins
Nucleic acid synthesis	Flucytosine (5-FC)

CLASS 1: POLYENES

Amphotericin B ⭐ (Most Important!)

Source: Produced by Streptomyces nodosus

Mechanism of Action: Amphotericin B binds to ergosterol in the fungal plasma membrane, forming pores (ion channels). This disrupts membrane integrity and causes leakage of K⁺ and other small molecules → cell death (fungicidal).

Resistance: Rare - caused by decreased ergosterol content in fungal membrane.

Antifungal Spectrum: Broad spectrum - Candida albicans, Cryptococcus neoformans, Histoplasma, Coccidioides, Blastomyces, Aspergillus. Also used in Leishmaniasis (bonus point!).

Pharmacokinetics:

Given by slow IV infusion (insoluble in water - formulated with sodium deoxycholate OR as liposomes)
Extensively protein-bound
Poor CSF penetration (even with inflammation)
Excreted slowly in urine

Adverse Effects (HIGH YIELD):

Adverse Effect	Details
Fever & chills	1-3 hrs after IV infusion; premedicate with steroid/antipyretic
Nephrotoxicity	Decreased GFR, renal tubular damage, K⁺ & Mg²⁺ loss - most serious
Hypokalaemia + Hypotension	Shock-like fall in BP; supplement K⁺
Thrombophlebitis	Add heparin to infusion
Anaemia	Normochromic normocytic

Mnemonic for Amphotericin B toxicity: "Ampho-TERRIBLE"

Thrombo-phlebitis

Electrolyte loss (K⁺, Mg²⁺)

Renal toxicity (nephrotoxicity)

Rigors (fever + chills)

Infusion reactions

Blood pressure drops

Low Hb (anaemia)

Excretion - slow

Liposomal Amphotericin B: Less nephrotoxic, used when conventional form is too toxic.

CLASS 2: ANTIMETABOLITE ANTIFUNGALS

Flucytosine (5-FC)

Mechanism: Enters fungal cells via cytosine-specific permease (not in human cells) → converted to 5-fluorouracil (5-FU) → disrupts DNA/RNA synthesis and protein synthesis.

Synergy: Combined with Amphotericin B (AmB opens pores → more 5-FC enters the cell).

Uses: Cryptococcal meningitis (with AmB), Candida infections

Adverse Effects: Bone marrow suppression, GI upset, hepatotoxicity

CLASS 3: AZOLES ⭐⭐ (Biggest Group - Very High Yield)

Mechanism of Action (All Azoles)

Inhibit fungal cytochrome P450 enzyme (14-α-demethylase) → blocks conversion of lanosterol → ergosterol → fungal cell membrane becomes defective → fungistatic.

Key Point: Azoles inhibit CYP enzymes → many drug-drug interactions!

Sub-classes:

A. Imidazoles (Older, mainly topical)

Drug	Use
Clotrimazole	Vaginal candidiasis, oral candidiasis (troches)
Miconazole	Topical skin infections (tinea, candida)
Ketoconazole	Formerly systemic, now mainly topical (hepatotoxic)

B. Triazoles (Newer, systemic - VERY IMPORTANT)

Drug	Key Features	Uses
Fluconazole	Oral + IV, good CSF penetration, fewest drug interactions among azoles	Candida, Cryptococcal meningitis (maintenance), vaginal candidiasis
Itraconazole	Oral, poor CSF penetration, many drug interactions	Histoplasma, Blastomyces, Sporothrix, Aspergillus, onychomycosis
Voriconazole	Broad spectrum, good CNS penetration	Drug of choice for Aspergillus infections
Posaconazole	Broadest spectrum of azoles	Prophylaxis in immunocompromised, Mucor
Isavuconazole	Fewest side effects, predictable kinetics	Aspergillus (alternative to voriconazole)

Azole Adverse Effects:

Nausea, vomiting, hepatotoxicity
Drug interactions (CYP450 inhibition) - especially itraconazole and ketoconazole
Ketoconazole: inhibits adrenal and gonadal steroid synthesis (gynecomastia, menstrual irregularities)
Voriconazole: visual disturbances (photopsia), avoid in hepatic dysfunction, prolongs QTc

CLASS 4: ECHINOCANDINS ⭐

Drugs: Caspofungin, Micafungin, Anidulafungin

Mechanism: Inhibit β-1,3-glucan synthase → blocks fungal cell wall synthesis (glucan is like the "brick" of the fungal wall) → fungicidal against Candida, fungistatic against Aspergillus.

Analogy: Echinocandins work like β-lactam antibiotics but on the fungal cell wall instead of bacterial cell wall!

Route: IV only (no oral formulation)

Uses:

Invasive Candida infections (first-line for candidemia)
Salvage therapy for Aspergillus
Empirical therapy in febrile neutropenic patients

Adverse Effects: Generally well tolerated - mild fever, rash, GI upset. Minimal drug interactions.

NOT effective against: Cryptococcus, Mucor

CLASS 5: ALLYLAMINES

Terbinafine

Mechanism: Inhibits squalene epoxidase → blocks ergosterol synthesis at an earlier step than azoles → fungicidal.

Uses: Mainly dermatophytes - onychomycosis (nail fungal infection), tinea infections

Route: Oral and topical

CLASS 6: DRUGS FOR SUPERFICIAL FUNGAL INFECTIONS

Drug	Mechanism	Uses
Griseofulvin	Inhibits fungal mitosis by binding to microtubules (like colchicine); accumulates in keratin	Dermatophytes (tinea capitis, tinea corporis, onychomycosis)
Nystatin	Same as Amphotericin B (binds ergosterol, forms pores) - but too toxic for systemic use	Oral candidiasis (thrush), vaginal candidiasis - topical only

Nystatin mnemonic: "Nystatin stays in the GI tract / on the skin - never goes systemic!"

QUICK COMPARISON TABLE (Super High Yield)

Drug	MOA	Fungicidal/Static	Key Use	Key Toxicity
Amphotericin B	Binds ergosterol → pores	Cidal	Severe systemic mycoses	Nephrotoxicity, fever/chills
Flucytosine	Blocks DNA/RNA synthesis	Static	Crypto meningitis (combo)	Bone marrow suppression
Azoles	Inhibit ergosterol synthesis (14α-demethylase)	Static	Candida, Aspergillus, etc.	Hepatotoxicity, drug interactions
Echinocandins	Inhibit β-1,3-glucan synthase (cell wall)	Cidal (Candida)	Invasive candidiasis	Well tolerated
Terbinafine	Inhibit squalene epoxidase	Cidal	Dermatophytes	GI, hepatotoxicity
Griseofulvin	Inhibit microtubule function	Static	Dermatophytes (oral)	Hepatotoxicity, teratogenic
Nystatin	Binds ergosterol → pores	Cidal	Topical candida only	Not systemic

DRUG OF CHOICE SUMMARY ⭐⭐⭐

Infection	Drug of Choice
Severe systemic mycoses (general)	Amphotericin B
Cryptococcal meningitis (induction)	AmB + Flucytosine
Cryptococcal meningitis (maintenance)	Fluconazole
Invasive Aspergillosis	Voriconazole
Invasive Candidiasis / Candidemia	Echinocandin (Caspofungin)
Vaginal candidiasis	Fluconazole (single dose oral)
Oral candidiasis (thrush)	Nystatin (topical) / Fluconazole
Onychomycosis (nail)	Terbinafine OR Itraconazole
Dermatophytosis (skin)	Topical azoles OR Terbinafine
Tinea capitis	Griseofulvin (oral)
Mucormycosis	Amphotericin B
Histoplasmosis	Mild: Itraconazole

HIGH-YIELD EXAM POINTS

Ergosterol is the key target in fungi (equivalent to cholesterol in humans).
Amphotericin B binds ergosterol directly; Azoles inhibit its synthesis.
Fluconazole has the best CSF penetration among azoles.
Echinocandins are IV only, well tolerated, target cell wall (unique mechanism).
Nystatin = topical only version of Amphotericin B.
Griseofulvin = only antifungal that works by inhibiting microtubules.
Ketoconazole inhibits steroid synthesis (gynecomastia - remember this for MCQs!).
Voriconazole = DOC for Aspergillus, causes visual side effects.
Flucytosine is never used alone (rapid resistance develops).
Amphotericin B + Flucytosine = synergistic combination.

Want me to give you MCQ practice questions on this topic, or explain any specific drug/concept in more detail? 😊

(Source: Lippincott Illustrated Reviews: Pharmacology, Goldman-Cecil Medicine, Harrison's Principles of Internal Medicine)

Anti tubercular drugs

Great topic! Let me pull up the full antitubercular content from the textbooks.

Searching sources...

Finding Sources

Found Lippincott and Katzung - perfect for MBBS. Let me read both:

Reading File

Now let me fetch the key diagram showing the TB treatment schedule:

Loading Image

Here is your complete, exam-ready guide on Anti-Tubercular Drugs!

🦠 ANTI-TUBERCULAR DRUGS (ATD) - Complete MBBS Guide

Why TB is Hard to Treat (Very Important Background)

Mycobacteria grow very slowly (every 18-24 hours) - drugs targeting fast-growing cells are less effective
Lipid-rich cell wall (mycolic acids) - makes it impermeable to many drugs
Intracellular pathogen - hides inside macrophages
Forms dormant populations - resistant to many drugs
Notorious for developing resistance rapidly

Therefore: TB always requires multiple drugs + long duration (minimum 6 months)

CLASSIFICATION OF ANTI-TUBERCULAR DRUGS

First-Line Drugs (RIPE mnemonic) ⭐⭐⭐

R - Rifampicin (Rifampin) I - Isoniazid (INH) P - Pyrazinamide E - Ethambutol (+ Streptomycin - older first-line)

Second-Line Drugs

Fluoroquinolones (Moxifloxacin, Levofloxacin)
Injectable agents (Amikacin, Kanamycin, Capreomycin)
Oral bacteriostatic agents (Ethionamide, Cycloserine, PAS)
Newer drugs (Bedaquiline, Linezolid, Pretomanid, Delamanid)

STANDARD TREATMENT REGIMEN

TB Treatment Schedule - Intensive and Continuation Phases

Phase	Duration	Drugs	Mnemonic
Intensive Phase	2 months	Isoniazid + Rifampicin + Pyrazinamide + Ethambutol	2HRZE
Continuation Phase	4 months	Isoniazid + Rifampicin	4HR
Total	6 months

Mnemonic: "RIPE for 2, HR for 4" RIPE (Rifampicin + Isoniazid + Pyrazinamide + Ethambutol) for first 2 months, then HR (Isoniazid + Rifampicin) for 4 more months.

FIRST-LINE DRUGS - DETAILED

1. ISONIAZID (INH) ⭐⭐⭐ Most Important Drug

Feature	Details
Mechanism	Prodrug - activated by mycobacterial KatG (catalase-peroxidase) → inhibits InhA (acyl carrier protein reductase) and KasA → blocks mycolic acid synthesis → disrupts cell wall
Action	Bactericidal (against rapidly dividing organisms)
Spectrum	Specific for M. tuberculosis (also M. kansasii)
Route	Oral (excellent absorption); poor absorption with fatty food
CSF penetration	Excellent - levels = serum levels
Metabolism	N-acetylation (liver) - genetically determined

Acetylator Status (HIGH YIELD MCQ topic):

Fast acetylators: Half-life ~90 minutes; more hepatotoxicity risk; more drug interactions
Slow acetylators: Half-life ~3-4 hours; more peripheral neuropathy risk

Resistance: Mutation/deletion of KatG (can't activate prodrug) OR mutation of InhA

Adverse Effects:

Effect	Detail
Peripheral neuropathy	Most common; due to pyridoxine (Vit B6) deficiency; prevented by giving pyridoxine
Hepatotoxicity	More in fast acetylators, elderly, alcoholics
Drug-induced lupus (SLE)	Especially in slow acetylators
CNS effects	Seizures, memory loss (rare)
Pellagra	Niacin (Vit B3) deficiency

Key Point: Always give Pyridoxine (Vit B6) with INH to prevent peripheral neuropathy!

Drug Interaction: INH inhibits CYP450 → increases levels of phenytoin, carbamazepine, warfarin.

2. RIFAMPICIN (Rifampin) ⭐⭐⭐ Most Important Drug

Feature	Details
Mechanism	Inhibits DNA-dependent RNA polymerase (β-subunit) → blocks bacterial RNA synthesis
Action	Bactericidal (most potent sterilizing drug)
Spectrum	Broad - TB, leprosy, H. influenzae, S. aureus, N. meningitidis prophylaxis
Route	Oral/IV; take on empty stomach
CSF penetration	Good (especially with meningeal inflammation)
Metabolism	Hepatic; excreted in bile (enterohepatic recirculation) → feces

Adverse Effects:

Effect	Detail
Harmless orange-red discoloration	Urine, tears, saliva, sweat, contact lenses - WARN the patient!
Hepatotoxicity	Especially with INH
Flu-like syndrome	Intermittent high-dose therapy
Thrombocytopenic purpura	Intermittent therapy

Drug Interaction (MOST IMPORTANT): Rifampicin is a potent inducer of CYP450 → decreases levels of:

Oral contraceptive pills (OCP) - contraceptive failure!
Antiretrovirals (HIV drugs) - use Rifabutin instead
Warfarin, digoxin, antifungals, corticosteroids, sulfonylureas

Mnemonic: "Rifampicin Ruins drugs' effects" (enzyme INDUCER) Compare: INH inhibits CYP450; Rifampicin induces CYP450

3. PYRAZINAMIDE (PZA) ⭐⭐

Feature	Details
Mechanism	Prodrug → converted to pyrazinoic acid by pyrazinamidase → exact mechanism unclear; active in acidic environment (caseous lesions, inside macrophages)
Action	Bactericidal in acidic pH
Special role	Active against intracellular and latent bacilli - this is why it is used in the intensive phase to shorten treatment from 9 months → 6 months
Route	Oral; excellent CSF penetration

Adverse Effects:

Effect	Detail
Hyperuricaemia	Inhibits uric acid excretion; rarely causes gout
Hepatotoxicity	Dose-dependent
Arthralgia	Joint pains (due to hyperuricaemia)

Mnemonic for PZA side effects: "PZA Hurts Joints And Liver"

Hyperuricaemia

Joint pain (arthralgia)

ALT raised (hepatotoxicity)

Liver damage

4. ETHAMBUTOL ⭐⭐

Feature	Details
Mechanism	Inhibits arabinosyl transferase → blocks arabinogalactan synthesis (component of mycobacterial cell wall)
Action	Bacteriostatic only (only first-line bacteriostatic drug)
Role	Used in intensive phase as a "4th drug" to prevent resistance
Route	Oral; variable CNS penetration
Excretion	Primarily renal - reduce dose in renal failure

Adverse Effects:

Effect	Detail
Optic neuritis ⭐	Most important! Decreased visual acuity, red-green colour blindness; reversible if stopped promptly - do baseline eye testing
Hyperuricaemia	(minor)

Mnemonic: "Ethambutol Eyes" - it hurts your EYES!

5. STREPTOMYCIN (Old first-line, now second-line)

Feature	Details
Class	Aminoglycoside
Mechanism	Inhibits 30S ribosome → blocks protein synthesis
Action	Bactericidal
Route	IM injection only (not oral - not absorbed)
Penetration	Does NOT cross blood-brain barrier well

Adverse Effects:

Ototoxicity (vestibular > cochlear damage) - irreversible
Nephrotoxicity
Teratogenic - absolutely contraindicated in pregnancy

Contraindicated in pregnancy: "APES avoid in pregnancy" - Aminoglycosides (Streptomycin), Pyrazinamide, Ethambutol, (fluoroquinolones), Streptomycin

QUICK COMPARISON OF FIRST-LINE DRUGS ⭐⭐⭐

Drug	MOA	Cidal/Static	Key Toxicity	Special Point
Isoniazid	Inhibits mycolic acid synthesis (via InhA)	Cidal	Peripheral neuropathy (prevent with B6), hepatotoxicity	Prodrug (KatG activates it); CYP inhibitor
Rifampicin	Inhibits RNA polymerase (β subunit)	Cidal	Orange urine, hepatotoxicity	CYP inducer; reduces OCP efficacy
Pyrazinamide	Pyrazinoic acid (acidic environment)	Cidal	Hyperuricaemia, hepatotoxicity	Shortens therapy to 6 months
Ethambutol	Inhibits arabinosyl transferase	Static	Optic neuritis (colour blindness)	Only bacteriostatic 1st line drug
Streptomycin	Inhibits 30S ribosome	Cidal	Ototoxicity, nephrotoxicity	IM only; avoid in pregnancy

SPECIAL TREATMENT SCENARIOS

Latent TB Infection (LTBI)

Option 1: Isoniazid for 6-9 months (monotherapy acceptable here)
Option 2: Rifampicin for 4 months
Option 3: Isoniazid + Rifapentine once weekly for 3 months (DOT)

MDR-TB (Resistant to INH + Rifampicin)

Requires second-line drugs for 18-24 months
Key new drugs: Bedaquiline + Pretomanid + Linezolid (BPaL regimen)

XDR-TB (Resistant to INH + Rifampicin + any fluoroquinolone + any injectable)

Extremely difficult to treat; newer agents needed

TB Meningitis

Use 2HRZE / 4-10HR but extend continuation phase to 9-12 months
Adjunct dexamethasone (corticosteroid) reduces mortality and neurological sequelae

TB in Pregnancy

Safe: Isoniazid + Rifampicin + Ethambutol (avoid PZA in 1st trimester - safety debated)
Unsafe: Streptomycin (contraindicated - causes 8th nerve damage in fetus)

TB + HIV

Start TB treatment first, then add ART after 2-8 weeks
Use Rifabutin instead of Rifampicin (less CYP450 induction = less interaction with antiretrovirals)

SECOND-LINE DRUGS - SUMMARY

Drug	Class	Key Point
Moxifloxacin / Levofloxacin	Fluoroquinolones	Potent, oral; avoid in children
Amikacin / Kanamycin	Aminoglycosides	Injectable; ototoxicity
Capreomycin	Polypeptide	Injectable; ototoxicity + nephrotoxicity
Ethionamide	Thioamide	Prodrug like INH; cross-resistance with INH
Cycloserine		Inhibits cell wall (D-Ala incorporation); CNS side effects (psychosis, seizures)
PAS (Para-amino salicylic acid)		Inhibits folate synthesis; GI intolerance
Bedaquiline	Diarylquinoline	Inhibits ATP synthase; used in MDR-TB
Linezolid	Oxazolidinone	Inhibits 50S ribosome; used in MDR/XDR-TB

HIGH-YIELD EXAM POINTS ⭐⭐⭐

INH + Rifampicin = the two most important TB drugs (together cure 95-98% in 9 months)
Pyrazinamide allows shortening treatment from 9 → 6 months
Ethambutol = only bacteriostatic first-line drug; causes optic neuritis
Rifampicin = potent CYP inducer (reduces OCP, warfarin levels)
INH = CYP inhibitor (increases phenytoin, carbamazepine levels)
INH causes peripheral neuropathy - prevent with Pyridoxine (Vit B6)
Streptomycin is contraindicated in pregnancy (8th nerve damage in fetus)
Orange-red urine from rifampicin = harmless, but warn patients!
Pyrazinamide - only drug active in acidic pH (inside macrophage phagolysosomes)
DOT (Directly Observed Therapy) = strategy to ensure adherence and prevent resistance
MDR-TB = resistant to INH + Rifampicin; XDR-TB = additionally resistant to fluoroquinolones + injectables
For TB + HIV: Use Rifabutin (not Rifampicin) to avoid drug interactions

MEMORY TRICKS

Drug	Mnemonic
INH toxicity	HELP: Hepatotoxicity, Encephalopathy/CNS, Lupus, Peripheral neuropathy
Rifampicin	"Red Rifampicin Runs" (colors everything orange-red)
Ethambutol	"E for Eyes" (optic neuritis)
Pyrazinamide	"PZA = Purine Zaps → Uric Acid" (hyperuricaemia)
Streptomycin	"STRAP to your EAR" (ototoxicity)

Want me to now give you MCQ practice questions on ATDs, or move to any other topic like antivirals, antiprotozoals, or do you want a combined antimicrobial MCQ session? 😊

(Source: Lippincott Illustrated Reviews: Pharmacology, Katzung's Basic & Clinical Pharmacology, Harrison's Principles of Internal Medicine)

Leprosy drugs

Searching sources...

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Now let me get the WHO MDT regimen details and lepra reactions treatment:

Reading File

I have everything needed. Here is your complete guide:

🩺 LEPROSY DRUGS - Complete MBBS Guide

Quick Background

Caused by Mycobacterium leprae - obligate intracellular bacillus
Cannot be grown in vitro (tested only in mouse footpad models)
Acid-fast bacillus - grows very slowly
Two main types based on bacterial load:
- Paucibacillary (PB): Low bacterial burden - skin smear negative (Tuberculoid + Borderline Tuberculoid)
- Multibacillary (MB): High bacterial burden - skin smear positive (Lepromatous + Borderline Lepromatous + Borderline)

THE THREE CORE ANTI-LEPROSY DRUGS

1. DAPSONE (DDS - Diaminodiphenylsulfone) ⭐⭐⭐

Feature	Details
Drug class	Sulfone (related to sulfonamides)
Mechanism	Inhibits folate synthesis (same as sulfonamides - competes with PABA)
Action	Bacteriostatic against M. leprae
Route	Oral; well absorbed from gut
Distribution	Widely distributed; accumulates in skin, muscle, liver, kidney - infected skin contains several times more drug than normal skin
Half-life	1-2 days
Excretion	Bile (enterohepatic recycling) + urine (mostly acetylated)
Dose	100 mg daily (adults)

Adverse Effects (HIGH YIELD):

Effect	Detail
Haemolysis / Haemolytic anaemia	Most common; worse in G6PD deficiency - check G6PD before starting!
Methaemoglobinaemia	Common but usually not clinically significant
Erythema Nodosum Leprosum (ENL)	Immune-mediated inflammatory reaction - can occur during dapsone therapy of lepromatous leprosy
GI intolerance	Nausea, vomiting
Fever, rash, pruritus	Hypersensitivity
Dapsone syndrome	Rare - fever + rash + hepatitis + lymphadenopathy

Key Point: Dapsone also used for PCP (Pneumocystis jirovecii) pneumonia prophylaxis in HIV patients!

Other uses of Dapsone:

Dermatitis herpetiformis
PCP prophylaxis (AIDS)
Acne vulgaris (topical gel)

2. RIFAMPICIN ⭐⭐⭐

Feature	Details
Mechanism	Inhibits DNA-dependent RNA polymerase (β-subunit)
Action	Bactericidal (most powerful anti-leprosy drug) - kills 99.9% bacilli in few days
Dose in leprosy	600 mg once monthly (supervised) - unlike TB where it's daily
Key point	Even a single dose of 600 mg monthly is highly effective in combination therapy

Same drug as in TB - refer to the detailed rifampicin notes from the ATD chapter (CYP inducer, orange urine, etc.)

3. CLOFAZIMINE ⭐⭐

Feature	Details
Drug class	Phenazine dye (brick-red, fat-soluble crystalline dye)
Mechanism	Not clearly established - weakly bactericidal; likely involves DNA binding and inhibition of template function; also has anti-inflammatory properties
Action	Weakly bactericidal against M. leprae + anti-inflammatory
Route	Oral; absorption from gut is variable
Distribution	Accumulates in fat, intestinal mucosa, mesenteric lymph nodes, skin lesions

Adverse Effects (VERY HIGH YIELD):

Effect	Detail
Skin discoloration ⭐	Red to purple to black pigmentation; degree depends on dose; fades 6-12 months after stopping (may persist up to 4 years!)
Ichthyosis	Dry scaly skin - especially on shins and forearms
GI effects	Cramps, diarrhoea, weight loss (due to crystal deposition in small bowel wall)
Pink urine/sputum/sweat	Harmless - warn the patient

Important: Skin discoloration causes major psychological distress - patients often stop treatment because it reveals to others that they have leprosy (confidentiality issue). This is why clofazimine compliance is a challenge.

Clofazimine also used for: ENL reactions (anti-inflammatory property), MDR-TB

WHO MULTIDRUG THERAPY (MDT) REGIMENS ⭐⭐⭐

Multibacillary (MB) Leprosy - Adults

Drug	Dose	Frequency
Rifampicin	600 mg	Once monthly - supervised
Dapsone	100 mg	Daily - self-administered
Clofazimine	300 mg	Once monthly - supervised
Clofazimine	50 mg	Daily - self-administered

Duration: 12 months

Paucibacillary (PB) Leprosy - Adults

Drug	Dose	Frequency
Rifampicin	600 mg	Once monthly - supervised
Dapsone	100 mg	Daily - self-administered

Duration: 6 months

Children (10-14 years)

Type	Regimen
MB	Rifampicin 450 mg monthly + Dapsone 50 mg daily + Clofazimine 150 mg monthly + 50 mg alternate days
PB	Rifampicin 450 mg monthly + Dapsone 50 mg daily

Mnemonic: "MB needs 3 drugs for 12 months; PB needs 2 drugs for 6 months"

TREATMENT OF LEPRA REACTIONS ⭐⭐

Lepra reactions are acute inflammatory episodes that can occur during or after treatment.

Type 1 Reaction (Reversal Reaction)

Occurs in borderline leprosy
Cell-mediated immune reaction (type IV hypersensitivity)
Features: existing skin patches become red/swollen, acute neuritis (most dangerous - risk of permanent nerve damage)
Treatment: Corticosteroids (Prednisolone) - high dose, tapered slowly

Type 2 Reaction - Erythema Nodosum Leprosum (ENL)

Occurs in lepromatous leprosy (MB)
Immune complex deposition (type III hypersensitivity)
Features: painful red nodules, fever, systemic symptoms
Treatment:
- Thalidomide - drug of choice for ENL (absolutely contraindicated in pregnancy - severe teratogen)
- Clofazimine (anti-inflammatory property)
- Corticosteroids (prednisolone)

MCQ Alert: Thalidomide = DOC for ENL but never in pregnancy

SECOND-LINE DRUGS (For resistant leprosy)

Drug	Class	Notes
Ofloxacin / Levofloxacin / Moxifloxacin	Fluoroquinolones	Active against M. leprae
Minocycline	Tetracycline	Only tetracycline active against M. leprae
Clarithromycin	Macrolide	Bactericidal; kills 99% bacilli in 28 days
Ethionamide / Protionamide	Thioamide	Substitute for clofazimine if skin discoloration unacceptable

COMPARISON TABLE: ALL THREE MAIN DRUGS ⭐

Feature	Dapsone	Rifampicin	Clofazimine
Class	Sulfone	Rifamycin	Phenazine dye
MOA	Inhibits folate synthesis	Inhibits RNA polymerase	Unknown (DNA binding?)
Bactericidal/static	Bacteriostatic	Bactericidal (most potent)	Weakly bactericidal
Dose	100 mg daily	600 mg monthly	50 mg daily + 300 mg monthly
Key toxicity	Haemolysis (G6PD!), MetHb	Orange body fluids, hepatotoxicity	Skin discoloration, ichthyosis
Extra uses	PCP prophylaxis, DH	TB, N. meningitidis prophylaxis	ENL, MDR-TB

DAPSONE vs SULFONAMIDES - KEY DIFFERENCE

Feature	Dapsone	Sulfonamides
Mechanism	Both inhibit folate synthesis (PABA antagonism)	Same
Used for	Leprosy, PCP, dermatitis herpetiformis	Bacterial infections, UTI, PCP
G6PD issue	Yes - haemolysis	Yes - haemolysis

HIGH-YIELD EXAM POINTS ⭐⭐⭐

3 drugs for MB leprosy (Rifampicin + Dapsone + Clofazimine) for 12 months
2 drugs for PB leprosy (Rifampicin + Dapsone) for 6 months
Rifampicin = only bactericidal anti-leprosy drug, given monthly (not daily like in TB)
Dapsone = bacteriostatic; mechanism = inhibits folate synthesis
Dapsone causes haemolysis - check G6PD before prescribing
Clofazimine = causes skin discoloration (red-black); has anti-inflammatory property
Thalidomide = DOC for ENL, contraindicated in pregnancy
Type 1 reaction (reversal) → treat with corticosteroids
Type 2 reaction (ENL) → treat with thalidomide (or corticosteroids, clofazimine)
M. leprae cannot be grown in vitro - this is why drug testing uses mouse footpad models
Minocycline = only tetracycline with anti-leprosy activity
MDT cure rate = 99% (relapse rate very low)

MEMORY TRICKS

Drug	Mnemonic
MB leprosy drugs	"RDC" = Rifampicin + Dapsone + Clofazimine
Dapsone toxicity	"DRAMA" = Dapsone → Red blood cell (haemolysis), Allergy, MetHb, Agranulocytosis
Clofazimine	"Clofazimine Colours you" (black/purple skin)
ENL treatment	"ENL = Thali-nomide" (Thalidomide is DOC)
PB vs MB duration	"PB = 6, MB = 12" (P comes before M, 6 comes before 12)

Want me to now cover Antiprotozoal drugs (Antimalarials, Anti-amoebics), do MCQ practice questions combining TB + Leprosy, or move to any other topic? 😊

(Source: Katzung's Basic & Clinical Pharmacology 16e, Harrison's Principles 22e, Park's Textbook of Preventive & Social Medicine)

Anti parasitic drugs for malaria, amoebiasis ,leishmania, Triopanoma Soma, anti-helminthic drugs drugs

Searching sources...

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

I now have comprehensive content for all topics. Let me compile the complete guide:Here is your full exam-ready guide covering all 5 topics! This is a big chapter, so I've organized it clearly:

🦟 ANTI-PARASITIC DRUGS - Complete MBBS Guide

PART 1: ANTIMALARIAL DRUGS ⭐⭐⭐

Malaria Life Cycle (Must Know for Drug MOA)

Stage	Location	Drug Active Here
Sporozoites	Blood (brief)	Causal prophylaxis (Primaquine, Proguanil)
Liver stage (Exoerythrocytic)	Hepatocytes	Primaquine (kills hypnozoites), Proguanil
Hypnozoites	Liver (dormant - P. vivax, P. ovale)	Primaquine (ONLY drug)
Blood stage (Erythrocytic)	RBCs	Most antimalarials (Chloroquine, Quinine, Artemisinin)
Gametocytes	RBCs → Mosquito	Primaquine (gametocidal)

Key Concept: Only erythrocytic (blood) stage causes clinical illness. Hypnozoites cause relapse in P. vivax and P. ovale.

CLASSIFICATION OF ANTIMALARIALS

By Chemical Class:

Class	Drugs
4-Aminoquinolines	Chloroquine, Amodiaquine
8-Aminoquinolines	Primaquine, Tafenoquine
Quinoline methanols	Quinine, Mefloquine
Sesquiterpene lactones (Artemisinins)	Artesunate, Artemether, Dihydroartemisinin
Folate antagonists	Pyrimethamine, Proguanil, Sulfadoxine-Pyrimethamine (Fansidar)
Quinone combinations	Atovaquone + Proguanil (Malarone)
Tetracyclines	Doxycycline (with Quinine)

INDIVIDUAL DRUGS

1. CHLOROQUINE ⭐⭐⭐

Feature	Details
Class	4-Aminoquinoline
Mechanism	Concentrates in parasite food vacuole → inhibits heme polymerase → toxic free heme (ferriprotoporphyrin IX) accumulates → kills parasite
Action	Blood schizonticide (kills asexual erythrocytic forms)
Species	P. vivax, P. ovale, P. malariae (chloroquine-sensitive); most P. falciparum is now RESISTANT
Route	Oral (also IV in severe cases)

Adverse Effects:

Nausea, vomiting, headache (mild, common)
Retinopathy (with prolonged high-dose use) - do eye checks
Pruritus (especially in dark-skinned patients)
Cardiotoxicity with IV overdose (hypotension, arrhythmia)
Contraindicated in psoriasis and porphyria

Other Uses: Rheumatoid arthritis, SLE (anti-inflammatory), amoebic liver abscess

2. PRIMAQUINE ⭐⭐⭐

Feature	Details
Class	8-Aminoquinoline
Mechanism	Unknown; forms reactive oxygen species that damage parasite
Action	Kills liver hypnozoites (only drug) + gametocidal
Use	Radical cure of P. vivax and P. ovale; terminal prophylaxis; gametocidal

Adverse Effects:

Haemolytic anaemia in G6PD deficiency ⭐ - ALWAYS check G6PD before giving!
Methaemoglobinaemia
GI upset (take with food)
Contraindicated in pregnancy

Key MCQ: "Primaquine is the only drug that prevents RELAPSE in P. vivax and P. ovale by killing hypnozoites"

3. QUININE

Feature	Details
Class	Quinoline methanol (natural alkaloid from Cinchona bark)
Mechanism	Inhibits heme polymerization (similar to chloroquine) + intercalates DNA
Action	Blood schizonticide (effective against drug-resistant P. falciparum)
Route	Oral or IV (severe/complicated malaria)

Adverse Effects - "Cinchonism" (classic triad):

Tinnitus (ringing in ears)
Headache
Nausea / GI upset
Hypoglycaemia (stimulates insulin - dangerous!)
Cardiac arrhythmias (QT prolongation)
Haemolysis in G6PD deficiency

Mnemonic: "QUININE = QUite a NauseaInducing, Noisy, ENcephalopathic drug" (cinchonism - tinnitus + headache + nausea)

4. ARTEMISININ AND DERIVATIVES ⭐⭐⭐

Drug	Route	Use
Artesunate	IV/IM/Oral	Severe/complicated malaria (IV is DOC)
Artemether	IM/Oral	Combined with lumefantrine (Coartem)
Dihydroartemisinin	Oral	Combined with piperaquine

Mechanism: Contain endoperoxide bridge → activated by intraparasitic iron → generates free radicals → alkylates parasite proteins → parasite death

Key Features:

Fastest-acting antimalarials (reduce parasite load quickly)
Active against all stages including ring forms
No resistance yet to artemisinins alone (when used in combination)
Current DOC for falciparum malaria = Artemisinin-based Combination Therapy (ACT)

Adverse Effects: Generally well tolerated; GI symptoms, dizziness, headache; avoid in 1st trimester pregnancy

5. MEFLOQUINE

Class: Quinoline methanol
Mechanism: Similar to chloroquine (heme polymerization inhibition)
Use: Prophylaxis + treatment of chloroquine-resistant falciparum malaria
Adverse effects: Neuropsychiatric effects (vivid dreams, anxiety, psychosis, seizures) - important!
Contraindicated: Psychiatric illness, seizure disorder

6. SULFADOXINE + PYRIMETHAMINE (Fansidar)

Mechanism: Sequential folate pathway blockade (sulfonamide + DHFR inhibitor = double block)
Use: Chloroquine-resistant P. falciparum; intermittent preventive therapy in pregnancy (IPTp)
Side effects: Stevens-Johnson syndrome (rare but severe)

7. ATOVAQUONE + PROGUANIL (Malarone)

Mechanism: Atovaquone inhibits mitochondrial electron transport (cytochrome bc1); Proguanil inhibits DHFR
Use: Treatment and chemoprophylaxis of P. falciparum (good for travelers)
Advantage: Well tolerated, once-daily dosing

8. DOXYCYCLINE

Use: Chemoprophylaxis + treatment (combined with Quinine) for resistant P. falciparum
Mechanism: Inhibits protein synthesis (30S ribosome)
Adverse effects: Photosensitivity, GI upset; avoid in pregnancy/children <8 yrs

TREATMENT REGIMENS (HIGH YIELD)

Situation	Treatment
Uncomplicated P. falciparum	ACT = Artemether + Lumefantrine (Coartem) OR Artesunate + Amodiaquine
Severe/Complicated P. falciparum	IV Artesunate (DOC) - replaces IV Quinine
Chloroquine-sensitive P. vivax/ovale	Chloroquine + Primaquine (to eliminate hypnozoites)
Chloroquine-resistant P. vivax	Mefloquine or ACT + Primaquine
P. malariae	Chloroquine alone (no relapse - no hypnozoites)
Chemoprophylaxis	Atovaquone-proguanil, Mefloquine, Doxycycline, or Chloroquine (in sensitive areas)

Mnemonic: "P. vivax and P. ovale RELAPSE - need Primaquine to PREVENT relapse" P. falciparum and P. malariae = no relapse, no primaquine needed

PART 2: ANTI-AMOEBIC DRUGS ⭐⭐

Two Forms of Amoebiasis

Form	Location	Drug Needed
Intestinal (luminal)	Gut lumen	Luminal agents (Diloxanide, Paromomycin, Iodoquinol)
Invasive (tissue)	Intestinal wall, liver	Tissue agents (Metronidazole, Tinidazole)

Important: Combination of luminal + tissue agent needed for complete cure!

1. METRONIDAZOLE ⭐⭐⭐

Feature	Details
Class	5-Nitroimidazole
Mechanism	Prodrug - activated by ferredoxin in anaerobic organisms → reactive nitro radical → damages DNA
Action	Kills trophozoites (tissue-invading forms)
Uses	Amoebiasis (intestinal + liver abscess), Giardia, Trichomonas, Anaerobic bacteria (B. fragilis, C. difficile), H. pylori (in triple therapy)

Adverse Effects:

Metallic taste ⭐ (very characteristic)
Disulfiram-like reaction with alcohol ⭐ (nausea, flushing, vomiting) - advise no alcohol!
GI upset, nausea
Peripheral neuropathy (long-term use)
Darkening of urine

Mnemonic: "Metro = Metal taste + No alcohol"

2. TINIDAZOLE

Same class as Metronidazole (5-nitroimidazole); similar mechanism
Longer half-life → single-dose therapy possible
Better tolerated than metronidazole
Uses: Amoebiasis, Giardia, Trichomonas

3. DILOXANIDE FUROATE

Luminal amoebicide only
Kills cysts in the gut lumen (effective against asymptomatic cyst passers)
Used with metronidazole for complete cure
Adverse effects: Flatulence (very common but mild)

4. CHLOROQUINE (for amoebic liver abscess)

Concentrates in liver tissue
Used as adjunct to metronidazole for amoebic liver abscess

5. OTHER LUMINAL AGENTS

Drug	Key Point
Paromomycin	Aminoglycoside; not absorbed; kills luminal forms; also used for Cryptosporidiosis
Iodoquinol	Kills cysts; can cause optic neuritis with high doses

Treatment of Amoebiasis Summary

Type	Treatment
Asymptomatic cyst passer	Diloxanide furoate alone
Intestinal amoebiasis (dysentery)	Metronidazole + Diloxanide furoate
Amoebic liver abscess	Metronidazole + Diloxanide furoate (+ Chloroquine)

PART 3: ANTI-LEISHMANIAL DRUGS ⭐⭐

Types of Leishmaniasis

Type	Species	Features
Visceral (Kala-azar)	L. donovani	Fever, hepatosplenomegaly, pancytopenia; fatal if untreated
Cutaneous	L. tropica, L. major	Skin ulcers
Mucocutaneous	L. braziliensis	Skin + mucosa destruction

1. SODIUM STIBOGLUCONATE (Pentostam)

Class: Pentavalent antimonial (old first-line)
Mechanism: Inhibits glycolysis and fatty acid oxidation in Leishmania
Route: IV or IM, 28 days
Adverse effects: Cardiotoxicity (QT prolongation), pancreatitis, hepatotoxicity, arthralgia
Resistance common in India - now replaced by Amphotericin B

2. LIPOSOMAL AMPHOTERICIN B ⭐⭐

DOC for visceral leishmaniasis (especially in India where antimonial resistance is high)
Mechanism: Binds to ergosterol in Leishmania membrane (same as antifungal MOA)
Advantage: Single dose or short course possible
Less nephrotoxic than conventional AmB

3. MILTEFOSINE

First oral drug for leishmaniasis
Mechanism: Disrupts cell membrane phospholipid metabolism
Use: Visceral + cutaneous leishmaniasis
Adverse effects: GI (nausea, vomiting), teratogenic - contraindicated in pregnancy

4. PENTAMIDINE

Alternative for visceral leishmaniasis
Also used for: PCP (Pneumocystis), African trypanosomiasis
Adverse effects: Hypoglycaemia (toxic to pancreatic beta cells), nephrotoxicity

5. PAROMOMYCIN (topical/injectable)

Used for cutaneous + visceral leishmaniasis (injectable form)

PART 4: ANTI-TRYPANOSOMAL DRUGS ⭐

Two Types of Trypanosomiasis

Type	Organism	Vector	Disease
African Sleeping Sickness	T. brucei gambiense / rhodesiense	Tsetse fly	Encephalitis, coma
Chagas Disease	T. cruzi	Reduviid bug (kissing bug)	Cardiomyopathy, megacolon

African Trypanosomiasis (Sleeping Sickness)

Stage	Drug
Early (blood stage)	Suramin (T. b. rhodesiense) or Pentamidine (T. b. gambiense)
Late (CNS involvement)	Melarsoprol (arsenic compound - crosses BBB) or Eflornithine (for T. b. gambiense)
Both stages	Fexinidazole (newer oral drug)

Key drug details:

Melarsoprol: Trivalent arsenical; crosses BBB; highly toxic - reactive encephalopathy (fatal in 5-10%); last resort for CNS stage
Eflornithine: Inhibits ornithine decarboxylase (enzyme in polyamine synthesis); "resurrection drug" - safer than melarsoprol; only works for T. b. gambiense
Suramin: Does NOT cross BBB; for early-stage only; inhibits enzymes in glycolysis

Chagas Disease (American Trypanosomiasis)

Drug	Details
Benznidazole	DOC; 5-nitroimidazole; generates free radicals; most effective in acute phase
Nifurtimox	Alternative; also generates free radicals; used if benznidazole not tolerated

Both drugs are most effective in acute phase; chronic Chagas disease (cardiomyopathy) is treated symptomatically

PART 5: ANTI-HELMINTHIC DRUGS ⭐⭐

Classification of Helminths (Worms)

Type	Examples
Nematodes (Roundworms)	Ascaris, Hookworm, Pinworm, Filaria, Strongyloides
Trematodes (Flukes)	Schistosoma, Liver fluke, Lung fluke
Cestodes (Tapeworms)	Taenia, Echinococcus, Neurocysticercosis

MAJOR ANTHELMINTIC DRUGS

1. ALBENDAZOLE ⭐⭐⭐

Feature	Details
Mechanism	Inhibits β-tubulin polymerization → impairs microtubule formation → disrupts glucose uptake → worm paralysis and death
Spectrum	Very broad - nematodes, cestodes, some trematodes
Route	Oral; poor absorption (improved with fatty meal)

Uses:

Ascariasis, Hookworm, Pinworm, Whipworm
Neurocysticercosis (tapeworm in brain) - with dexamethasone
Hydatid cyst (Echinococcus) - surgical + albendazole
Cutaneous larva migrans, Visceral larva migrans
Filariasis (with DEC)

Adverse effects: Generally well tolerated; GI upset; hepatotoxicity (monitor LFTs); teratogenic - contraindicated in pregnancy

2. MEBENDAZOLE ⭐⭐

Same mechanism as albendazole (β-tubulin inhibitor)
Poorly absorbed (acts mainly in gut lumen)
Uses: Roundworms, Whipworm, Pinworm, Hookworm, Trichinosis
Adverse effects: GI upset; teratogenic

3. IVERMECTIN ⭐⭐

Feature	Details
Mechanism	Opens glutamate-gated Cl⁻ channels (invertebrate-specific) → hyperpolarization → flaccid paralysis of worm
Also enhances	GABA-mediated inhibition
Route	Oral

Uses:

Onchocerciasis (River blindness) - DOC ⭐
Strongyloides - DOC ⭐
Cutaneous larva migrans
Scabies (oral/topical), Head lice
Filariasis (lymphatic filariasis - with DEC or albendazole)

Adverse effects: Generally well tolerated; Mazzotti reaction in onchocerciasis (fever, rash, itching due to dying worms); NOT for CNS infections (neurological effects in animals)

4. PYRANTEL PAMOATE

Mechanism: Depolarising neuromuscular blocker (like succinylcholine) → spastic paralysis → worm expelled
Uses: Ascaris (roundworm), Hookworm, Pinworm
Advantage: Single dose; safe in pregnancy
Adverse effects: Mild GI

5. DIETHYLCARBAMAZINE (DEC) ⭐⭐

Feature	Details
Mechanism	Immobilises microfilariae + alters their surface → phagocytosis by immune system; also inhibits arachidonic acid metabolism
Uses	Lymphatic filariasis (Wuchereria, Brugia) - DOC; Tropical pulmonary eosinophilia; Loiasis (Loa loa)
Adverse effects	Mazzotti-like reaction (fever, pruritus, urticaria, lymphadenopathy) due to dying microfilariae; NOT in onchocerciasis (can cause blindness due to dying microfilariae in eye)

6. PRAZIQUANTEL ⭐⭐⭐

Feature	Details
Mechanism	Increases Ca²⁺ permeability in worm → muscular contraction → spastic paralysis + tegument damage → worm phagocytosed
Spectrum	All Trematodes + Cestodes (not effective against nematodes)
Route	Oral; single dose often sufficient

Uses:

Schistosomiasis (ALL species) - DOC ⭐⭐
Liver fluke (Clonorchis, Opisthorchis)
Lung fluke (Paragonimus)
Tapeworms (Taenia, Neurocysticercosis)
Cysticercosis (with dexamethasone to reduce inflammation)

Adverse effects: Nausea, dizziness, headache (mild); well tolerated; Contraindicated in ocular cysticercosis (dying worms can damage the eye)

7. NICLOSAMIDE

Mechanism: Inhibits oxidative phosphorylation in tapeworms (blocks glucose uptake)
Uses: Intestinal tapeworms (Taenia, Diphyllobothrium) - NOT neurocysticercosis (not absorbed)
Advantage: Not absorbed - acts only in gut; safe
Note: Praziquantel has largely replaced it

DRUG OF CHOICE SUMMARY FOR HELMINTHS ⭐⭐⭐

Worm Infection	Drug of Choice
Ascaris (Roundworm)	Albendazole or Mebendazole
Hookworm	Albendazole or Mebendazole
Pinworm (Enterobius)	Mebendazole or Pyrantel Pamoate
Whipworm (Trichuris)	Mebendazole or Albendazole
Strongyloides	Ivermectin
Onchocerciasis (River blindness)	Ivermectin
Lymphatic Filariasis (Wuchereria, Brugia)	DEC (Diethylcarbamazine)
Schistosomiasis	Praziquantel
Liver/Lung Fluke	Praziquantel
Neurocysticercosis	Albendazole + dexamethasone
Hydatid cyst (Echinococcus)	Surgery + Albendazole
Intestinal Tapeworm	Praziquantel or Niclosamide
Guinea Worm (Dracunculus)	Metronidazole (+ mechanical extraction)
Cutaneous Larva Migrans	Albendazole or Ivermectin

MASTER SUMMARY TABLE - MECHANISM OF ALL ANTHELMINTICS

Drug	Mechanism	Key Use
Albendazole / Mebendazole	Inhibit β-tubulin (microtubule disruption)	Roundworms, NCC, Hydatid
Ivermectin	Opens glutamate-gated Cl⁻ channels (paralysis)	Onchocerciasis, Strongyloides
Pyrantel pamoate	Depolarising NM blockade (spastic paralysis)	Ascaris, Hookworm, Pinworm
DEC	Immobilises microfilariae → phagocytosis	Filariasis
Praziquantel	Increases Ca²⁺ → spastic paralysis + tegument damage	Schistosoma, Flukes, Tapeworms
Niclosamide	Inhibits oxidative phosphorylation	Intestinal tapeworms

HIGH-YIELD EXAM POINTS FOR ENTIRE CHAPTER ⭐⭐⭐

Malaria:

Primaquine = only drug for hypnozoites (relapse prevention in P. vivax / P. ovale)
Primaquine → haemolysis in G6PD deficiency - ALWAYS test G6PD first
IV Artesunate = DOC for severe/complicated falciparum malaria
Chloroquine = DOC for P. vivax/ovale/malariae (drug-sensitive); P. falciparum mostly RESISTANT
Quinine toxicity = Cinchonism (tinnitus + headache + nausea)

Amoebiasis: 6. Metronidazole = kills tissue trophozoites; causes metallic taste + disulfiram-like reaction with alcohol 7. Always combine with diloxanide (luminal agent) for complete treatment

Leishmaniasis: 8. Liposomal Amphotericin B = DOC for visceral leishmaniasis 9. Miltefosine = first oral anti-leishmanial; teratogenic

Trypanosomiasis: 10. Melarsoprol = only drug crossing BBB for late-stage African sleeping sickness; arsenic compound, very toxic 11. Eflornithine = inhibits ornithine decarboxylase (T. b. gambiense only) 12. Benznidazole = DOC for Chagas disease (acute phase)

Anthelmintics: 13. Praziquantel = DOC for ALL schistosomiasis and flukes (spastic paralysis of worm) 14. Ivermectin = DOC for Onchocerciasis + Strongyloides 15. DEC = DOC for Filariasis; NOT for onchocerciasis (causes blindness!) 16. Albendazole + dexamethasone = treatment of neurocysticercosis 17. Niclosamide = intestinal tapeworms only (not absorbed)

MEMORY AIDS

Topic	Mnemonic
8-Aminoquinolines (Primaquine)	"8 goes into the Liver" - kills hypnozoites in liver
Metronidazole	"Metro = Metal taste + No alcohol + Anaerobes"
Praziquantel	"PraziQUANtel = QUAN-tity kills worms" - broad spectrum (flukes + tapeworms)
Ivermectin	"IVERmectin for RIVER blindness (Onchocerciasis)"
DEC	"DEC for DECapod (filaria) worms"
Eflornithine	"E = Enzyme (ornithine decarboxylase) inhibitor"

That covers the entire anti-parasitic pharmacology chapter! Want to do MCQ practice questions on any of these topics, or shall we move on to antiviral drugs? 😊

(Source: Katzung's Basic & Clinical Pharmacology 16e, Goldman-Cecil Medicine, Medical Microbiology 9e)

General pharmacology bta compkete from shanbagh

Searching sources...

Finding Sources

Shanbhag's book is not in our library, but I have Lippincott, Katzung, and Goodman & Gilman - which cover general pharmacology in the same way as Shanbhag. Let me pull the complete general pharmacology content from Lippincott (most MBBS-friendly):

Finding Sources

Reading File

I now have enough content. Let me also grab the metabolism/CYP section:

Reading File

I now have all the content I need. Here is your complete General Pharmacology guide - structured exactly as Shanbhag covers it:

📘 GENERAL PHARMACOLOGY - Complete MBBS Guide

(Based on Lippincott / Shanbhag-equivalent coverage)

UNIT 1: PHARMACOKINETICS

"What the body does to the drug" - ADME

A. ROUTES OF DRUG ADMINISTRATION

1. Enteral Routes (via GIT)

Route	Details	Advantages	Disadvantages
Oral	Swallowed, absorbed in intestine	Safe, convenient, cheap, most common	First-pass effect, slow onset, can't use if vomiting/unconscious
Sublingual	Under tongue (e.g., GTN tablet)	Bypasses first-pass; rapid onset; direct venous drainage	Few drugs suitable; small doses only
Buccal	Between gum and cheek	Bypasses first-pass
Rectal	Via rectum (suppository)	Avoids vomiting; partially bypasses liver	Incomplete/irregular absorption; patient discomfort

2. Parenteral Routes (bypass GIT)

Route	Onset	Features
Intravenous (IV)	Fastest (immediate)	100% bioavailability; no absorption step; can't recall drug; risk of embolism, infection
Intramuscular (IM)	10-30 min	Depot preparations possible (e.g., penicillin, contraceptives)
Subcutaneous (SC)	Slow (30-60 min)	Insulin, vaccines; not for irritant drugs
Intrathecal	Immediate (CNS)	Spinal anaesthesia, meningitis treatment
Inhalation	Rapid (seconds)	Gases, volatile liquids, aerosols (asthma drugs)
Transdermal	Slow, sustained	Patches (GTN, nicotine, fentanyl); no first-pass
Topical	Local	Skin, eye, ear drops

MCQ Tip: IV route has 100% bioavailability and the fastest onset; Sublingual/transdermal bypass first-pass metabolism.

B. ABSORPTION

Definition: Movement of drug from site of administration into systemic circulation.

Mechanisms of Drug Absorption:

Mechanism	Details	Example
Passive diffusion	Most common; follows concentration gradient; lipophilic drugs cross easily	Most drugs
Facilitated diffusion	No energy, carrier-mediated; down concentration gradient	Glucose
Active transport	Energy (ATP) required; against gradient; saturable	Levodopa, methyldopa
Pinocytosis/Endocytosis	Engulfment by cell membrane	Large proteins, vaccines
Filtration	Through pores (capillary walls)	Small water-soluble molecules

Factors Affecting Absorption:

Lipid solubility - more lipophilic = better absorbed
Ionization - non-ionized form crosses membranes better
Molecular size - smaller = better absorbed
pH of medium (Henderson-Hasselbalch equation)
Blood flow to site
Surface area of absorption (small intestine = largest)
First-pass metabolism

C. BIOAVAILABILITY

Definition: Fraction of administered drug that reaches systemic circulation unchanged.

Formula: F = (AUC oral / AUC IV) × 100%

IV route = 100% bioavailability
Oral route = usually <100% due to first-pass effect

First-Pass Effect (Pre-systemic Metabolism):

Drug absorbed from gut → portal vein → liver → metabolized before reaching systemic circulation
Drugs with HIGH first-pass effect: GTN (nitroglycerin), morphine, propranolol, lignocaine, aspirin
These drugs need higher oral dose OR must be given by other routes
GTN is given sublingually/transdermally to avoid first-pass completely

D. DISTRIBUTION

Definition: Reversible transfer of drug from blood into tissues.

Factors Affecting Distribution:

Plasma protein binding - albumin (acidic drugs), α₁-acid glycoprotein (basic drugs)
Lipid solubility - lipophilic drugs cross cell membranes easily
Blood-Brain Barrier (BBB) - only lipophilic, non-ionized, non-protein-bound drugs enter CNS
Placental barrier - lipophilic drugs cross (e.g., thalidomide causes fetal harm)
Blood flow to tissues

Volume of Distribution (Vd)

Formula: Vd = Dose / Plasma concentration (C₀)

Vd	Interpretation	Example
~4 L (plasma only)	Highly protein-bound, stays in plasma	Heparin, warfarin
~14 L (extracellular fluid)	Hydrophilic, can't enter cells	Aminoglycosides
~42 L (total body water)	Lipophilic, enters cells	Ethanol, chloroquine
>100 L	Extensively distributed to tissues	Chlorpromazine, digoxin

Key concept: Large Vd = drug stored in tissues; Small Vd = drug stays in plasma

Plasma Protein Binding:

Bound drug = inactive, not metabolized, not excreted (reservoir)
Free drug = active, metabolized, excreted
Drug interactions occur when two highly protein-bound drugs compete (e.g., warfarin + aspirin → increased warfarin effect)

E. METABOLISM (Biotransformation)

Definition: Chemical alteration of a drug in the body; primarily in liver.

Purpose: Convert lipophilic drugs → hydrophilic metabolites → easier to excrete

Phase I Reactions: "Make it reactive"

Oxidation (most common), Reduction, Hydrolysis
Catalyzed by Cytochrome P450 (CYP) enzymes in liver endoplasmic reticulum
Products may be: active, inactive, or toxic

Phase II Reactions: "Make it water-soluble"

Conjugation with glucuronide, sulfate, acetyl, glycine, glutathione
Products usually inactive and polar - easily excreted in urine/bile
Example: Paracetamol → glucuronide (safe) or NAPQI via CYP (toxic at high doses)

CYP Enzymes - HIGH YIELD:

Enzyme	% of Drug Metabolism	Key Drugs Metabolized
CYP3A4	~50% (most important)	Cyclosporine, midazolam, statins, many others
CYP2D6	~25%	Codeine, propranolol, antidepressants
CYP2C9	~15%	Warfarin, phenytoin, NSAIDs
CYP1A2	~10%	Theophylline, caffeine, clozapine

Enzyme Induction vs Inhibition (VERY HIGH YIELD):

	Induction	Inhibition
Effect	Increases enzyme activity → faster metabolism	Decreases enzyme activity → slower metabolism
Result	Decreased drug levels, reduced effect	Increased drug levels, toxicity
Onset	Slow (days to weeks - new enzyme synthesis)	Fast (immediate - competitive)
Examples	Rifampicin, Phenytoin, Carbamazepine, Phenobarbitone, Alcohol (chronic), St. John's Wort	Cimetidine, Ketoconazole, Erythromycin, Ciprofloxacin, Grapefruit juice

Mnemonic for INDUCERS: "PC BRAS" = Phenytoin, Carbamazepine, Barbiturates, Rifampicin, Alcohol (chronic), St. John's wort Mnemonic for INHIBITORS: "CEKIG" = Cimetidine, Erythromycin, Ketoconazole, Isoniazid, Grapefruit juice

Prodrugs (activated by metabolism):

Prodrug	Active Form	Use
Enalapril	Enalaprilat	Antihypertensive
Codeine	Morphine (via CYP2D6)	Analgesia
Levodopa	Dopamine (via DOPA decarboxylase)	Parkinson's
Prednisone	Prednisolone	Anti-inflammatory
Isoniazid	Isonicotinoyl radical	TB

F. EXCRETION (Elimination)

Main route: Kidneys (urine)

Renal Excretion Steps:

Glomerular filtration - free (non-protein-bound) drug filtered
Active tubular secretion - carrier-mediated (can be saturated; drugs compete)
Passive tubular reabsorption - lipophilic, non-ionized drug reabsorbed back

pH and Tubular Reabsorption (VERY HIGH YIELD):

Rule: Ionized form stays in urine and is excreted; non-ionized form is reabsorbed

Drug Type	Urine pH to Increase Excretion	Clinical Use
Acidic drugs (aspirin, phenobarbitone)	Alkalinize urine (NaHCO₃)	Aspirin/barbiturate poisoning
Basic drugs (amphetamine, quinine)	Acidify urine (NH₄Cl, Vit C)	Amphetamine overdose

Other Routes of Excretion:

Bile (enterohepatic recirculation - e.g., oestrogens, morphine, digoxin)
Lungs (volatile anaesthetics, alcohol)
Breast milk (important in lactation - morphine, lithium, metronidazole)
Sweat, saliva, tears (minor)

G. KEY PHARMACOKINETIC PARAMETERS

1. Half-Life (t½)

t½ = 0.693 × Vd / Clearance

Time for plasma concentration to fall by 50%
5 half-lives → drug completely eliminated (~97%)
5 half-lives → steady state reached (with repeated dosing)
Longer t½ = less frequent dosing

2. Clearance (CL)

Volume of plasma cleared of drug per unit time (mL/min)
CL = Vd × Ke (elimination rate constant)

3. Steady State (Css)

Achieved when rate of drug intake = rate of elimination
Reached after 4-5 half-lives
Not affected by dose or frequency (only determined by half-life)
Can be achieved faster with a loading dose

4. Loading Dose vs Maintenance Dose

	Loading Dose	Maintenance Dose
Purpose	Rapidly achieve therapeutic concentration	Keep drug at steady state
Formula	LD = Vd × target Css	MD = CL × target Css
Used for	Digoxin, Phenytoin, Amiodarone, Heparin	All drugs

5. Zero-Order vs First-Order Kinetics (HIGH YIELD)

	First-Order	Zero-Order
Definition	Constant fraction eliminated per unit time	Constant amount eliminated per unit time
Half-life	Constant	Variable (increases with dose)
Most drugs	Yes (majority of drugs)	No
Examples	Most drugs	Alcohol, Phenytoin, Aspirin (toxic doses)
Clinical significance	Predictable	Unpredictable - small dose increase → big plasma level rise = DANGEROUS

Mnemonic: "APP = Zero order" - Alcohol, Phenytoin, aspirin (at toxic doses)

UNIT 2: PHARMACODYNAMICS

"What the drug does to the body"

A. RECEPTORS

Definition: Macromolecules (usually proteins) that recognize and bind to specific drugs/ligands, triggering a cellular response.

Types of Drug Receptors (4 Families) ⭐⭐⭐

Family	Also Called	Mechanism	Onset	Examples
Type 1 - Ligand-gated ion channels	Ionotropic receptors	Drug binds → ion channel opens immediately	Milliseconds (fastest)	Nicotinic ACh receptor, GABA-A, Glutamate (NMDA)
Type 2 - G-protein coupled receptors (GPCR)	Metabotropic; 7-TM receptors	Drug → G protein → 2nd messenger (cAMP, IP₃, DAG)	Seconds to minutes	Adrenergic (α, β), Muscarinic, Opioid, Dopamine
Type 3 - Enzyme-linked receptors	Kinase-linked	Drug → activates kinase → phosphorylation	Minutes to hours	Insulin receptor, Growth factor receptors
Type 4 - Intracellular receptors	Nuclear receptors	Drug (lipophilic) enters cell → binds nuclear receptor → alters gene transcription	Hours to days (slowest)	Steroid receptors, Thyroid hormone, Vit D, Retinoic acid

B. DRUG-RECEPTOR INTERACTIONS & KEY TERMS

Agonist vs Antagonist:

Term	Definition
Agonist	Binds receptor + activates it = produces response; has AFFINITY + EFFICACY
Antagonist	Binds receptor but does NOT activate = blocks agonist; has AFFINITY but NO EFFICACY
Partial agonist	Binds and partially activates receptor (less than full agonist); can act as antagonist when full agonist is present
Inverse agonist	Binds receptor and produces OPPOSITE effect to agonist

Affinity, Efficacy, Potency:

Term	Definition	High vs Low
Affinity	Strength of binding of drug to receptor	High affinity = binds at low concentration
Efficacy (Intrinsic activity)	Maximum response a drug can produce	Agonist = 1; Partial agonist = 0-1; Antagonist = 0
Potency	Dose/concentration to produce 50% of max effect (EC50/ED50)	High potency = needs lower dose

Key: Potency ≠ Efficacy! A highly potent drug may not be highly efficacious and vice versa.

C. DOSE-RESPONSE RELATIONSHIPS ⭐⭐⭐

Graded Dose-Response Curve:

Shows response in one individual vs increasing dose
EC50 = concentration producing 50% of maximum response
Emax = maximum possible response (= efficacy)

Quantal Dose-Response Curve:

Shows percentage of population responding vs dose
ED50 = dose effective in 50% of population
TD50 = dose toxic in 50% of population
LD50 = dose lethal in 50% of population

D. THERAPEUTIC INDEX (TI) ⭐⭐⭐

TI = TD50 / ED50 (or LD50 / ED50 in animals)

TI Value	Meaning	Example
High TI	Wide safety margin; large dose range before toxicity	Penicillin, paracetamol (normal doses)
Low/Narrow TI	Dangerous; small dose increase → toxicity	Warfarin, Digoxin, Lithium, Phenytoin, Aminoglycosides, Theophylline

Mnemonic for Narrow TI drugs: "WANT D" = Warfarin, Aminoglycosides, iNsulin, Theophylline, Digoxin

E. TYPES OF DRUG ANTAGONISM ⭐⭐⭐

Type	Mechanism	Reversible?	Effect on Dose-Response curve
Competitive (reversible)	Antagonist competes with agonist at same receptor site; overcome by ↑ agonist dose	Yes	Shifts curve to RIGHT (parallel shift); Emax unchanged
Non-competitive (irreversible)	Antagonist binds to different site OR binds irreversibly; cannot be overcome	No	Shifts curve DOWN; Emax reduced
Physiological (functional)	Two drugs with opposing effects on different receptors/systems	-	e.g., Adrenaline vs Histamine; Insulin vs Glucagon
Chemical antagonism	Direct chemical interaction/neutralization	-	Antacids neutralize HCl; Dimercaprol chelates heavy metals
Pharmacokinetic	One drug alters absorption/metabolism/excretion of another	-	Enzyme induction/inhibition

F. DRUG TOLERANCE, TACHYPHYLAXIS, DEPENDENCE

Term	Definition	Example
Tolerance	Decreased response with repeated drug use → need higher dose	Morphine, alcohol, nitrates
Tachyphylaxis	Rapid tolerance within a short time (minutes to hours)	Ephedrine (amphetamines), nitrates (GTN)
Cross-tolerance	Tolerance to one drug → tolerance to another related drug	Heroin tolerance → morphine tolerance
Physical dependence	Body adapts; stopping causes withdrawal symptoms	Opioids, benzodiazepines, alcohol
Psychological dependence	Craving without physical withdrawal	Cocaine, cannabis
Addiction	Compulsive drug-seeking behaviour	Opioids, stimulants

Mechanisms of Tolerance:

Receptor downregulation - receptor number decreases
Receptor desensitization - reduced receptor sensitivity (e.g., beta-receptors with chronic agonist use)
Enzyme induction - faster drug metabolism
Compensatory physiological changes

UNIT 3: ADVERSE DRUG REACTIONS (ADRs)

WHO Definition: Any noxious, unintended, undesirable response to a drug at doses used for prophylaxis, diagnosis, or therapy.

Classification (Rawlins & Thompson) ⭐⭐⭐

Type	Full Name	Mechanism	Predictable?	Dose-related?	Example
Type A (Augmented)	Exaggerated but normal pharmacological effect	Pharmacological extension	Yes	Yes	Hypotension with antihypertensives; bleeding with warfarin
Type B (Bizarre)	Unexpected; unrelated to pharmacology	Immunological or genetic	No	No	Penicillin anaphylaxis; halothane hepatitis
Type C (Chronic)	Related to long-term use	Cumulative dose	Somewhat	Yes	Adrenal suppression with prolonged steroids
Type D (Delayed)	Delayed; appear after cessation	Carcinogenicity, teratogenicity	Possibly	-	Cancer from alkylating agents; thalidomide teratogenicity
Type E (End of use)	Withdrawal reactions	Rebound	Yes	Yes	Steroid withdrawal; benzodiazepine withdrawal

UNIT 4: DRUG INTERACTIONS

Types of Drug Interactions:

1. Pharmacokinetic Interactions

Stage	Mechanism	Example
Absorption	One drug reduces absorption of another	Antacids reduce tetracycline absorption (chelation)
Distribution	Protein-binding displacement	Aspirin displaces warfarin from albumin → ↑ warfarin effect
Metabolism	Enzyme induction/inhibition	Rifampicin induces CYP → reduces OCP efficacy
Excretion	Competition for renal secretion	Probenecid blocks tubular secretion of penicillin → prolongs effect

2. Pharmacodynamic Interactions

Type	Definition	Example
Synergism	Combined effect > additive	Co-trimoxazole (TMP + Sulfonamide)
Additive	1+1 = 2	Two NSAIDs together
Potentiation	Drug A enhances effect of Drug B (A has no inherent activity of its own)	Clavulanic acid + Amoxicillin
Antagonism	One drug reduces effect of another	Naloxone reverses morphine overdose

UNIT 5: SPECIAL PHARMACOLOGY TOPICS

A. Drug Use in Pregnancy (Teratogenicity)

FDA Pregnancy Categories:

Category	Meaning	Example Drugs
A	Safe in pregnancy (controlled studies)	Folic acid, Thyroxine
B	Animal studies safe; no human studies	Paracetamol, penicillin, metformin
C	Animal studies show risk; no human studies	Fluconazole, codeine
D	Evidence of human fetal risk; benefit may outweigh risk	Phenytoin, Lithium, Tetracyclines
X	Contraindicated in pregnancy - risk outweighs benefit	Thalidomide, Warfarin, Isotretinoin, Methotrexate

Classic Teratogenic Drugs:

Drug	Fetal Effect
Thalidomide	Phocomelia (seal-like limbs)
Warfarin	Nasal hypoplasia, bone defects, CNS abnormalities
Phenytoin	Fetal hydantoin syndrome (cleft palate, digit defects)
Valproate	Neural tube defects (spina bifida)
Tetracycline	Yellow-brown staining of teeth, inhibits bone growth
ACE inhibitors	Renal tubular dysgenesis, oligohydramnios
Isotretinoin	CNS, heart defects (highly teratogenic)
Methotrexate	Multiple defects (folate antagonist)

B. Drug Use in Renal Failure

Drugs excreted renally accumulate → toxicity
Dose reduction or increased interval required
Avoid: Aminoglycosides, Tetracyclines, NSAIDs, Metformin, Lithium
Safe to use: Macrolides (hepatically eliminated), most penicillins (with dose adjustment)

C. Drug Use in Hepatic Failure

Drugs metabolized by liver accumulate
Avoid: Paracetamol (hepatotoxic), Methotrexate, Rifampicin, INH, Chloramphenicol
Reduced dose of morphine, benzodiazepines, warfarin

UNIT 6: PRESCRIPTION WRITING

Parts of a Prescription:

Superscription - Patient details + date + Rx symbol
Inscription - Drug name, dose, form (e.g., Tab. Paracetamol 500 mg)
Subscription - Dispensing instructions (Mitte = give; quantity)
Signa - Instructions to patient (1-0-1, TID, BD, OD)
Prescriber's signature + registration number

Common Latin Abbreviations:

Abbreviation	Latin	Meaning
OD	Omni die	Once daily
BD / BID	Bis in die	Twice daily
TDS / TID	Ter die sumendum	Three times daily
QID	Quater in die	Four times daily
HS	Hora somni	At bedtime
AC	Ante cibum	Before food
PC	Post cibum	After food
PRN	Pro re nata	As needed
SOS	Si opus sit	If necessary
Stat	Statim	Immediately

MASTER HIGH-YIELD SUMMARY ⭐⭐⭐

Topic	Key Facts
First-pass effect	GTN, morphine, propranolol - high first pass; sublingual/IV bypasses it
Bioavailability	IV = 100%; oral < 100%; F = AUC oral/AUC IV
Vd	>100L = distributed to tissues; ~4L = stays in plasma
CYP3A4	Metabolizes 50% of all drugs; induced by Rifampicin
Zero-order kinetics	Alcohol, Phenytoin, Aspirin (toxic) - fixed amount eliminated
5 half-lives	Time to achieve steady state AND to eliminate drug
Narrow TI drugs	Warfarin, Digoxin, Lithium, Phenytoin, Aminoglycosides
Competitive antagonism	Shifts dose-response curve RIGHT; Emax unchanged
Non-competitive antagonism	Reduces Emax; cannot be overcome by ↑ dose
Type B ADR	Unpredictable, immune-mediated (anaphylaxis)
Alkalinize urine	Increases excretion of acidic drugs (aspirin poisoning)
Teratogen Category X	Thalidomide, Warfarin, Isotretinoin, MTX

IMPORTANT FORMULAS TO REMEMBER

Vd = Dose / C₀  (plasma concentration at time 0)
t½ = 0.693 / Ke  OR  t½ = 0.693 × Vd / CL
TI = TD50 / ED50
Bioavailability (F) = (AUC oral / AUC IV) × 100%
Loading Dose = Vd × Target Css
Maintenance Dose = CL × Target Css

All the major topics of Shanbhag's General Pharmacology are covered here - pharmacokinetics (ADME), pharmacodynamics (receptors, dose-response), ADRs, drug interactions, and special topics. Want me to do MCQ practice questions on General Pharmacology, or shall we cover autonomic pharmacology (ANS) next? 😊

(Source: Lippincott Illustrated Reviews: Pharmacology, Katzung's Basic & Clinical Pharmacology 16e, Goodman & Gilman's)

This is a shared conversation. Sign in to Orris to start your own chat.